UNSPSC 51131657: Ximelagatran

This classification denotes an anticoagulant agent with the molecular formula C24H35N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49HFB70472, chemically known as glycine, n-((1r)-1-cyclohexyl-2-((2s)-2-((((4-((hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ester ester but generally known as ximelagatran, which bears US NIH Compound Identifier 9574101. European Medicines Agency schedules Ximelagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16473MIG.

UNSPSC 51131657 Ximelagatran is a Commodity code that names a specific anticoagulant pharmaceutical, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical purchasing. Instead, the single posted opportunity — Sourcewell RFP #061626, due June 16, 2026 — is soliciting law enforcement equipment on behalf of a multi-state cooperative purchasing vehicle. This mismatch signals that the code shows little relevant recent activity aligned with its nominal pharmaceutical scope; the law enforcement equipment solicitation appears to be miscoded or represents an outlier use of the taxonomy within state and local procurement databases.

Sourcewell, a Minnesota local government unit and service cooperative operating under Washington state law (RCW 39.34), issued the RFP to establish a contracting solution available to thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, tribal governments, and other public entities throughout the United States and Canada. Named participants include Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County, all in Washington. Vendors must submit proposals through the Sourcewell Procurement Portal by June 16, 2026 at 3:30 p.m. Central Time; no set-aside designations, specific award values, or incumbent vendor information are identified in the available documentation. Given the disconnect between the code's pharmaceutical designation and the law enforcement equipment scope of the posted opportunity, business development professionals evaluating this code should verify current taxonomic alignment in state and local procurement systems before pursuing similar opportunities.